A recent epigenetic study on post-COVID-19 patients found a significantly differentially genomic region located in the vicinity of the ZNF385D gene by comparing severe versus mild COVID-19 patient groups (p  =  4.82 × 10−14). The gene discussed is ZNF385D; the disease is COVID-19.